Gara Jalqabaatti › Non-Hodgkin Lymphoma
Qorannoo klinikaalii Non-Hodgkin Lymphoma Ameerikaa Keessatti hirmaatuu
Qorannoo 127 Non-Hodgkin Lymphoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 31
- Houston, TXQorannoo 31
- Boston, MAQorannoo 26
- Nashville, TNQorannoo 21
- Philadelphia, PAQorannoo 20
- Baldwin Park, CAQorannoo 19
- Washington, DCQorannoo 18
- Chicago, ILQorannoo 18
- Atlanta, GAQorannoo 18
- Milwaukee, WIQorannoo 18
- Columbus, OHQorannoo 18
- Dallas, TXQorannoo 17
- Seattle, WAQorannoo 16
- Durham, NCQorannoo 16
- Portland, ORQorannoo 15
- Rochester, MNQorannoo 14
- Miami, FLQorannoo 14
- Omaha, NEQorannoo 14
- Denver, COQorannoo 14
- Salt Lake City, UTQorannoo 13
- Cleveland, OHQorannoo 13
- Mountain View, CAQorannoo 12
- St. Louis, MOQorannoo 11
- Aurora, COQorannoo 11
- Jacksonville, FLQorannoo 9
- Tampa, FLQorannoo 9
- San Francisco, CAQorannoo 9
- Cincinnati, OHQorannoo 9
- Los Angeles, CAQorannoo 9
- Cedar Rapids, IAQorannoo 8
- San Diego, CAQorannoo 8
- Ann Arbor, MIQorannoo 8
- Pittsburgh, PAQorannoo 8
- Baltimore, MDQorannoo 8
- Buffalo, NYQorannoo 7
- Birmingham, ALQorannoo 7
- Queens, NYQorannoo 7
- Kansas City, MOQorannoo 7
- Edison, NJQorannoo 7
- Clifton, NJQorannoo 7
Naannoon
- AlabamaQorannoo 7
- ArizonaQorannoo 14
- ArkansasQorannoo 5
- CaliforniaQorannoo 42
- ColoradoQorannoo 20
- ConnecticutQorannoo 8
- DelawareQorannoo 4
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 32
- GeorgiaQorannoo 21
- HawaiiQorannoo 3
- IdahoQorannoo 3
- IllinoisQorannoo 20
- IndianaQorannoo 10
- IowaQorannoo 10
- KansasQorannoo 9
- KentuckyQorannoo 5
- LouisianaQorannoo 6
- MaineQorannoo 4
- MarylandQorannoo 21
- MassachusettsQorannoo 28
- MichiganQorannoo 13
- MinnesotaQorannoo 19
- MississippiQorannoo 3
- MissouriQorannoo 10
- MontanaQorannoo 3
- NebraskaQorannoo 15
- New JerseyQorannoo 13
- New MexicoQorannoo 4
- New YorkQorannoo 40
- North CarolinaQorannoo 24
- North DakotaQorannoo 3
- OhioQorannoo 34
- OklahomaQorannoo 3
- OregonQorannoo 15
- PennsylvaniaQorannoo 26
- Rhode IslandQorannoo 5
- South CarolinaQorannoo 5
- South DakotaQorannoo 3
- TennesseeQorannoo 24
- TexasQorannoo 48
- UtahQorannoo 14
- VirginiaQorannoo 13
- WashingtonQorannoo 20
- West VirginiaQorannoo 3
- WisconsinQorannoo 20
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04728893Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06176690Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01853631Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07763210CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07582432T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06343311CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05442515A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05645107NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07052305Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03223610Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01676805Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05907759A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06563596TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT01087333A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04002947A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.